“…The outcomes of the preliminary biological evaluations of the compounds ( S )‐ 1 , ( R )‐ 1 , (±)‐ 1 , ( S )‐ 2 , ( R )‐ 2 , (±)‐ 3 to (±)‐ 6 , (±)‐ 11 to (±)‐ 15 , 16 , (±)‐ 22 , (±)‐ 28 , (±)‐ 29 , (±)‐ 30 and (±)‐ 31 presented in the preceding section reveals an interesting structure activity relationship profile for a significant cross‐section of the family of bromopyrrole‐containing marine natural products. These results reinforce the notion that this scaffold represents something of a privileged structure for the purposes of drug development [7–13] . Again, our work in this area is ongoing and results will be reported in due course.…”